Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
This study will identify important barriers to and facilitators of translating an efficacious diabetes prevention intervention (Group Lifestyle Balance, GLB) into routine clinical practice, outside of a research context.
Aims include: (1) Evaluate the clinical effectiveness of GLB, (2) Evaluate the impact of GLB on healthcare utilization, costs, and cost-effectiveness, and (3) Evaluate GLB implementation within and across Sutter Health regions and clinics.
Principal Investigator
Kristen M.J. Azar, R.N., BSN, MSN/MPH
Co-Investigator(s)
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Related Studies
A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians.
Managing Cardiometabolic Disease in Primary Care
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Research Aimed at Improving Both Mood and Weight (RAINBOW)
Strength Training Regimen for Normal Weight Diabetics (STRONG-D) Study
New Weigh of Life Program Evaluation
eCMP (electronic Cardiometabolic Program)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Evaluation of Chronic Care Transformation at PAMF
Investigator: Cheryl Stults, Ph.D.